ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 21 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,229 | -45.3% | 11,429 | +1.2% | 0.00% | – |
| Q2 2023 | $29,681 | -56.8% | 11,297 | -40.1% | 0.00% | – |
| Q1 2023 | $68,687 | -7.7% | 18,870 | -0.2% | 0.00% | – |
| Q4 2022 | $74,450 | +84502.3% | 18,908 | -8.8% | 0.00% | – |
| Q3 2022 | $88 | -99.9% | 20,729 | +69.8% | 0.00% | – |
| Q1 2022 | $68,000 | -52.8% | 12,205 | -6.0% | 0.00% | – |
| Q1 2021 | $144,000 | – | 12,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lee Capital Holdings LLC | 11,805 | $46,482 | 0.07% |
| Susquehanna International Group Ltd. | 18,887 | $72,073 | 0.03% |
| Compagnie Lombard Odier SCmA | 50,000 | $190,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $50,700 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11,746 | $46,250 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 33,445 | $131,774 | 0.00% |
| Sargent Bickham Lagudis LLC | 15 | $59 | 0.00% |
| GOLDMAN SACHS GROUP INC | 18,908 | $74,450 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |